Evidence map›Paper›PMID 32813895›Full record

ArticleJournal of clinical hypertension (Greenwich, Conn.)2020

Prognostic implications of left ventricular hypertrophy diagnosed on electrocardiogram vs echocardiography.

Line Reinholdt Pedersen, Anna Meta Dyrvig Kristensen, Søren Sandager Petersen, Muthiah Vaduganathan, Deepak L Bhatt, Jacob Juel, Christina Byrne, Margrét Leósdóttir, Michael H Olsen, Manan Pareek

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical hypertension (Greenwich, Conn.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 3 countries.

Line Reinholdt PedersenCardiovascular and Metabolic Preventive Clinic, Department of Endocrinology, Centre for Individualized Medicine in Arterial Diseases (CIMA), Odense University Hospital, Odense, Denmark.
Anna Meta Dyrvig KristensenDepartment of Cardiology, North Zealand Hospital, Hillerød, Denmark.
Søren Sandager PetersenCardiovascular and Metabolic Preventive Clinic, Department of Endocrinology, Centre for Individualized Medicine in Arterial Diseases (CIMA), Odense University Hospital, Odense, Denmark.
Muthiah VaduganathanBrigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA, USA.
Deepak L BhattBrigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA, USA.
Jacob JuelDepartment of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
Christina ByrneDepartment of Cardiology, The Heart Centre, Rigshospitalet -Copenhagen University Hospital, Copenhagen, Denmark.
Margrét LeósdóttirDepartment of Cardiology, Skåne University Hospital, Malmö, Sweden.
Michael H OlsenCardiology Section, Department of Internal Medicine, Holbaek Hospital, Holbaek, Denmark.
Manan PareekDepartment of Cardiology, North Zealand Hospital, Hillerød, Denmark.ORCID 0000-0002-0867-5825
Brigham and Women's Hospital · USOdense University Hospital · DKAalborg University Hospital · DKCopenhagen University Hospital · DKHolbæk Sygehus · DKLund University · SEZealand University Hospital · DK

Funding

The Harvard Clinical and Translational Science CenterUL1TR002541 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2018 to 2022
$93.0M
NCATS NIH HHS UL1 TR002541
6 · The paper itself

Abstract

It is unclear whether 12-lead ECG employing standard criteria for left ventricular hypertrophy (LVH) provides similar information with respect to long-term cardiovascular risk as echocardiography. The authors performed a retrospective cohort study of 1376 individuals without cardiovascular disease, who underwent ECG (LVH defined using the Sokolow-Lyon voltage combination (>35 mm) or the Cornell voltage-duration product (>2440 mm × ms)) and echocardiography (LVH defined as LV mass index (LVMI) >95 g/m

Indexed as

Hypertrophy, Left VentricularAgedEchocardiographyElectrocardiographyFemaleHumansMaleMiddle AgedPrognosisRetrospective Studiesechocardiographyelectrocardiographyhypertrophy, left ventricularprognosisrisk assessment

Identifiers

PMID32813895
PMCPMC8029835
OpenAlexW3072097356

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.